Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

InspireMD Inc Files Amended Registration Statement For Proposed Public Offering Of Common Stock


Thursday, 7 Mar 2013 05:53pm EST 

InspireMD Inc announced that it has filed an amended registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the resumption of a proposed underwritten public offering. Under the amended registration statement, the Company is offering $30 million worth of its shares of common stock. In addition, InspireMD intends to grant the underwriters a 30-day option to purchase up to an aggregate of 15 percent additional shares of common stock to cover over-allotments, if any. The Company intends to use the proceeds from the offering to support the worldwide commercialization of the MGuard Coronary in acute myocardial infarction, pursue FDA approval in the U.S., to redeem its convertible debentures, and for general corporate purposes. As part of the offering, the Company has applied to list its shares of common stock on the NYSE MKT. 

Company Quote

2.04
-0.03 -1.45%
4:00pm EDT